Vascular function of forearm microcirculation in postmenopausal women with type 2 diabetes: Potential benefit of hormone replacement therapy?

Climacteric

Volumn 6, Issue 1, 2003, Pages 31-37

  Ching, H L ^a   Watts, G F ^b   Dhaliwal, S S ^a   Barrett, P H R ^b   Stuckey, B G A ^a  

^a SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Hormone replacement therapy; Menopause; Plethysmography; Type 2 diabetes

Indexed keywords

CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; ESTRADIOL PLUS NORETHISTERONE ACETATE; ESTRONE SULFATE; MEDROXYPROGESTERONE ACETATE;

ADULT; AGED; ARTICLE; BLOOD FLOW; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CARDIOVASCULAR SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; FOREARM; HIGH RISK POPULATION; HORMONE SUBSTITUTION; HUMAN; HYPEREMIA; MICROCIRCULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL CIRCULATION; PLETHYSMOGRAPHY; POSTMENOPAUSE; PRIORITY JOURNAL; RESISTANCE BLOOD VESSEL; RISK BENEFIT ANALYSIS; STRAIN GAUGE PLETHYSMOGRAPH; VASCULAR RESISTANCE; VEIN OCCLUSION;

EID: 0347295924     PISSN: 13697137     EISSN: None     Source Type: Journal    
DOI: 10.1080/cmt.6.1.31.37     Document Type: Article

References (39)

1. Barrett-Connor E, Wingard DL. Sex differential in ischemic heart disease mortality in diabetics: a prospective population-based study. Am J Epidemiol 1983;118:489-96
2. Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. J Am Med Assoc 1998;280:605-52
3. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. J Am Med Assoc 2002;288:321-33
4. Watts GF, Playford DA. Dyslipoproteinaemia and hyperoxidative stress in the pathogenesis of endothelial dysfunction in non-insulin dependent diabetes mellitus: an hypothesis. Atherosclerosis 1998;141:17-30
5. Lieberman EH, Gerhard MD, Uehata A, et al. Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women. Ann Intern Med 1994;121:936-41
6. Majmudar NG, Robson SC, Ford GA. Effects of menopause, gender, and estrogen replacement the therapy on vascular nitric oxide activity. J Clin Endocrinol Metab 2000;85:1577-83
7. Sorensen KE, Dorup I, Hermann AP, Mosekilde L. Combined hormone replacement therapy does not protect women against the age-related decline in endothelium-dependent vasomotor function. Circulation 1998;97:1234-8
8. Perera M, Sattar N, Petrie JR, et al. The effects of transdermal estradiol in combination with oral norethisterone on lipoproteins, coagulation, and endothelial markers in postmenopausal women with type 2 diabetes: a randomized, placebo-controlled study. J Clin Endocrinol Metab 2001;86:1140-3
9. Lim SC, Caballero AE, Arora S, et al. The effect of hormonal replacement therapy on the vascular reactivity and endothelial function of healthy individuals and individuals with type 2 diabetes. J Clin Endocrinol Metab 1999;84:4159-64
10. Perera M, Petrie JR, Hillier C, et al. Hormone replacement therapy can augment vascular relaxation in postmenopausal women with type 2 diabetes. Hum Reprod 1999;17:497-502
11. Sowers JR. Diabetes mellitus and cardiovascular disease in women. Arch Intern Med 1998;158:617-21
12. Rifici VA, Khachadurian AK. The inhibition of low-density lipoprotein oxidation by 17-β estradiol. Metabolism 1992;41:1110-14
13. Sack MN, Rader DJ, Cannon RO III. Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women. Lancet 1994;343:269-70
14. Chen Z, Yuhanna IS, Galcheva-Gargova Z, Karas RH, Mendelsohn ME, Shaul PW. Estrogen receptor α mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest 1999;103:401-6
15. Williams MRI, Westerman RA, Kingwell BA, et al. Variations in endothelial function and arterial compliance during the menstrual cycle. J Clin Endocrinol Metab 2001;86:5389-95
16. Al-Khalili F, Eriksson M, Landgren BM, Schenck-Gustafsson K. Effect of conjugated estrogen on peripheral flow-mediated vasodilation in postmenopausal women. Am J Cardiol 1998;82:215-18
17. Sax FL, Cannon RO III, Hanson C, Epstein SE. Impaired forearm vasodilator reserve in patients with microvascular angina. Evidence of a generalized disorder of vascular function? N Engl J Med 1987;317:1366-70
18. Nitenberg A, Valensi P, Sachs R, Dali M, Aptecar E, Attali JR. Impairment of coronary vascular reserve and ACh-induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function. Diabetes 1993;42:1017-25
19. Watts GF, Herrmann S, Dogra GK, et al. Vascular function of the peripheral circulation in patients with nephrosis. Kidney Int 2001;60:182-9
20. Kannel WB, Hjortland MC, McNamara PM, Gordon T. Menopause and risk of cardiovascular disease: the Framingham study. Ann Intern Med 1976;85:447-52
21. Matthews KA, Meilahn E, Kuller LH, Kelsey SF, Caggiula AW, Wing RR. Menopause and risk factors for coronary heart disease. N Engl J Med 1989;321:641-6
22. Taddei S, Virdis A, Ghiadoni L, et al. Menopause is associated with endothelial dysfunction in women. Hypertension 1996;28:576-82
23. Playford D, Watts GF. Endothelial dysfunction, insulin resistance and diabetes: exploring the web of causality. Aust NZ J Med 1999;29:523-34
24. Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999;340:1801-11
25. McCrohon JA, Adams MR, McCredie RJ, et al. Hormone replacement therapy is associated with improved arterial physiology in healthy postmenopausal women. Clin Endocrinol 1996;45:435-41
26. Gerhard M, Walsh BW, Tawakol A, et al. Estradiol therapy combined with progesterone and endothelium-dependent vasodilation in postmenopausal women. Circulation 1998;98:1158-63
27. Bush DE, Jones CE, Bass KM, Walters GK, Bruza JM, Ouyang P. Estrogen replacement reverses endothelial dysfunction in postmenopausal women. Am J Med 1998;104:552-8
28. Kawano H, Motoyama T, Hirai N, et al. Effect of medroxyprogesterone acetate plus estradiol on endothelium-dependent vasodilation in postmenopausal women. Am J Cardiol 2001;87:238-40
29. Chan NN, MacAllister RJ, Colhoun HM, Vallance P, Hingorani AD. Changes in endothelium-dependent vasodilatation and α-adrenergic responses in resistance vessels during the menstrual cycle in healthy women. J Clin Endocrinol Metab 2001;86:2499-504
30. English JL, Jacobs LO, Green G, Andrews TC. Effect of the menstrual cycle on endothelium-dependent vasodilation of the brachial artery in normal young women. Am J Cardiol 1998;82:256-8
31. Palin SL, Kumar S, Sturdee DW, Barnett AH. Hormone replacement therapy for postmenopausal women with diabetes. Diabetes Obesity Metab 2001;3:187-93
32. Kaseta JR, Skafar DF, Ram JL, Jacober SJ, Sowers JR. Cardiovascular disease in the diabetic woman. J Clin Endocrinol Metab 1999;84:1835-8
33. Higashi Y, Sanada M, Sasaki S, et al. Effect of estrogen replacement therapy on endothelial function in peripheral resistance arteries in normotensive and hypertensive postmenopausal women. Hypertension 2001;37:651-7
34. Koh KK, Cardillo C, Bui MN, et al. Vascular effects of estrogen and cholesterol-lowering therapies in hypercholesterolemic postmenopausal women. Circulation 1999;99:354-60
35. Kawano H, Motoyama T, Hirashima O, et al. Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery. J Am Coll Cardiol 1999;34:146-54
36. Guetta V, Cannon RO. Cardiovascular effects of estrogen and lipid-lowering therapies in postmenopausal women. Circulation 1995;93:1928-37
37. Playford DA, Watts GF. Non-invasive measurement of endothelial function. Clin Exp Pharmacol Physiol 1998;25:640-3
38. Liu MY, Hattori Y, Fukao M, Sato A, Sakuma I, Kanno M. Alterations in EDHF-mediated hyperpolarization and relaxation in mesenteric arteries of female rats in long-term deficiency of oestrogen and during oestrus cycle. Br J Pharmacol 2001;132:1035-46
39. Mikkola T, Viinikka L, Ylikorkala O. Administration of transdermal estrogen without progestin increases the capacity of plasma and serum to stimulate prostacyclin production in human vascular endothelial cells. Fertil Steril 2000;73:72-4